Clinical Trials Browser

Phase 1/2 × OTHER × Hormone Refractory Prostate Cancer × Clear all

NCT00928252 2017-08-14

Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer

Phase 1/2 Completed

25 enrolled 9 charts

Hormone Refractory Prostate Cancer

NCT00906243 2012-04-04

RNActive®-Derived Therapeutic Vaccine

Phase 1/2 Terminated

6 enrolled 5 charts

Hormone Refractory Prostate Cancer